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Abstract
While genome-wide association studies (GWAS) and candidate gene approaches have identified many genetic variants that
contribute to disease risk as main effects, the impact of genotype by environment (GxE) interactions remains rather under-
surveyed. To explore the importance of GxE interactions for diabetes-related traits, a tool for Genome-wide Complex Trait
Analysis (GCTA) was used to examine GxE variance contribution of 15 macronutrients and lifestyle to the total phenotypic
variance of diabetes-related traits at the genome-wide level in a European American population. GCTA identified two key
environmental factors making significant contributions to the GxE variance for diabetes-related traits: carbohydrate for
fasting insulin (25.1% of total variance, P-nominal = 0.032) and homeostasis model assessment of insulin resistance (HOMA-
IR) (24.2% of total variance, P-nominal = 0.035), n-6 polyunsaturated fatty acid (PUFA) for HOMA-b-cell-function (39.0% of
total variance, P-nominal = 0.005). To demonstrate and support the results from GCTA, a GxE GWAS was conducted with
each of the significant dietary factors and a control E factor (dietary protein), which contributed a non-significant GxE
variance. We observed that GxE GWAS for the environmental factor contributing a significant GxE variance yielded more
significant SNPs than the control factor. For each trait, we selected all significant SNPs produced from GxE GWAS, and
conducted anew the GCTA to estimate the variance they contributed. We noted the variance contributed by these SNPs is
higher than that of the control. In conclusion, we utilized a novel method that demonstrates the importance of genome-
wide GxE interactions in explaining the variance of diabetes-related traits.
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Introduction
Type 2 diabetes (T2D) is one of the most common chronic
diseases in the world, accounting for nearly 90% to 95% of all
diabetes cases. Approximately 25.6 million adults in the U.S.A. [1]
and 285 million adults worldwide [2] were affected by diabetes in
2010, and it is estimated that between 2010 and 2030, the number
of adult diabetes cases will increase by 69% in developing
countries and by 20% in developed countries [2]. For the
prevention of T2D, identifying genetic and environmental risk
factors has been a primary research focus in the public health
arena. Thus far, more than 100 single-nucleotide polymorphisms
(SNP) for T2D and T2D-related traits have been identified via
genome-wide association studies (GWAS) (Hindorff et al. www.
genome.gov/gwastudies). However, the GWAS-identified genetic
variants explain only about 10% of T2D heritability [3,4]. The
‘‘missing heritability’’ may be attributed to variants of small effect,
rare variants, structural variants poorly captured by GWAS arrays,
copy number variants, weak linkage disequilibrium of genotype
variants with the causal variants, gene-gene interaction, and
genotype by environment (GxE) interaction [5,6]. Because GxE
interactions suggest a way by which genetic risk may be
ameliorated, these environmental factors are of great relevance
to public health, and are the focus of a growing number of studies
[7].
Environmental factors, such as diet and lifestyle, are important
in the onset, development and progression of T2D and its related
phenotypes [8,9]. The interactions of environmental factors with
genotypes contribute to the total genetic variance of a given trait
[10], and are important constituents of the total phenotypic
variance. While a number of studies have demonstrated the
significant effects of GxE on T2D and T2D-related traits [7,11], a
further clarification of the role of GxE at the genome-wide level
could help predict disease risk more accurately and help develop
dietary recommendations to improve prevention and treatment. In
addition, for T2D-related traits, such as insulin resistance and
pancreatic b-cell function, there are still no published data
examining to what extent variance of these traits are explained
by the GxE interaction at the genome-wide level. It is crucial to
estimate the proportion of GxE interaction variance for T2D-
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related traits in addition to the main effect of the genetic variants
because this produces a more complete understanding of the role
of environment with regard to these phenotypes. Furthermore, it is
of profound interest to understand which dietary or lifestyle factors
are the most influential for the variation of a given T2D-related
phenotype through GxE interactions and to what extent these
environmental factors contribute to the phenotypic variation. In
this study, we aimed to explore the variance contribution of GxE
interactions to four T2D-related traits at the genome-wide level in
a population of European ancestry living in the U.S.A.
Research Design and Methods
Study Population
A total of 820 subjects (406 men and 414 women) participating
in the Genetics of Lipid Lowering Drugs and Diet Network
(GOLDN) Study were included in the present study. All
participants were of European origin and re-recruited from
three-generational pedigrees in the two centers of the National
Heart, Lung, and Blood Institute Family Heart Study in
Minneapolis, MN, and Salt Lake City, UT. Details of the study
design and methodology for GOLDN were described [12]. The
T2D-related traits from the second visit at the baseline were used
for the analysis of this study. The study protocol was approved by
the Institutional Review Boards at the University of Minnesota,
University of Utah, and Tufts University. All participants gave
written informed consent.
Genome-wide Genotyping
Extraction and purification of genomic DNA have been
described [13]. Genome-wide genotyping was conducted by the
Affymetrix Genome-Wide Human SNP Array 6.0 (CA, USA) and
Birdseed calling algorithm [14], and 906,600 SNPs were
genotyped. A total of 590,000 SNPs among those genotyped
SNPs were selected for our genome-wide analysis after they met
the following criteria: minor allele frequency $5%, call rate
$96% and P-value $1.0E-6 for the Hardy-Weinberg equilibrium
(HWE) test, and there were negligible Mendelian errors within
family [15].
Determination of Dietary and Lifestyle Factors and T2D-
related Traits
A diet history questionnaire (DHQ) developed by National
Cancer Institute was used to assess dietary intake, and nutrient
intake was then estimated based on the DHQ and the national
dietary data (USDA Continuing Survey of Food Intakes by
Individuals) [16]. The DHQ has been validated in two studies
[17,18]. A questionnaire was used to assess lifestyle information. A
total of 15 dietary and lifestyle factors (Table 1) possibly related to
T2D-related traits based on the literature and our experience were
used for the GxE analysis. There were 12 dietary factors: glycemic
load, protein, total fat, saturated fat, monounsaturated fat
(MUFA), polyunsaturated fatty acid (PUFA), n-3 PUFA, n-6
PUFA, n-3: n-6 PUFA ratio, carbohydrate, fiber and trans-fat, and
three lifestyle factors: alcohol use, smoking status, and physical
activity. All the dietary intakes (except glycemic load) and alcohol
use were expressed as percentage of total energy intake and
categorized into quartiles for data analysis. Physical activity and
glycemic load were also categorized into quartiles, while smoking
status was grouped into three groups: non-smoker, past smoker
and current smoker.
Fasting glucose was measured by a hexokinase-mediated
reaction on the Hitachi commercial kit (Linco Research, St.
Charles, MO), fasting insulin was determined by a commercial kit
by radioimmunoassay (Linco Research, St. Charles, MO).
Homeostasis model assessment of insulin resistance (HOMA-IR)
and of b-cell function (HOMA-B) were estimated by Levy’s
computer model [19]. HOMA-IR, insulin and glucose were Box-
Cox transformed [20] to achieve normal distribution before
analysis.
Estimation of Variance Contribution by GxE Interaction
using GCTA
A tool for Genome-wide Complex Trait Analysis (GCTA) [21]
was used to assess the contribution of GxE interaction to the
phenotypic variations of T2D-related traits for each of the 15
dietary and lifestyle factors. Currently, GCTA is suitable for the
variance estimation only of continuous variables, and estimation
based on binary variables, such as disease status, are not possible.
By using a -gxe option, the GxE interaction effects were treated as
random effects in the model, while the main effects of the genetic
variants and environmental factors were treated as fixed effects.
Covariates in the model included age, sex, study center, kinship
and population structure. Population structure was estimated
based on principle component analysis using SVS (Golden Helix
Inc., Bozeman, MT.) [22,23], and three key principle components
were selected as covariates in the analysis. Heritability of GxE for
T2D-related traits was estimated as the GxE variance divided by
the total phenotypic variance. The main steps of running GCTA
in a Linux computer environment include: 1) generate bed, bim
and fam files for GWAS genotype data using PLINK; 2) generate
grm.gz and grm.id files using ‘‘–make-grm’’; 3) prepare a
phenotype file for each trait and a covariate file; 4) estimate the
GxE variance contribution by introducing a ‘‘-gxe’’ option.
GCTA Bootstrap Analysis
A bootstrap analysis was performed to determine if the
significant GCTA heritability estimates obtained from SNPs
identified in each GxE GWAS could be obtained by chance.
This was done for Insulin 6 Carbohydrate, HOMA-IR 6
Carbohydrate, and HOMA-B6Carbohydrate.
A perl script was written to extract 1000 random sets of 49, 51
or 39 (numbers corresponding to SNPs identified in each
significant GxE from above) SNPs from the GOLDN genotype
data. A Unix script was then written to generate data for bootstrap
analysis. For each of the 1000 sets of SNPs the script first created a
GRM file and second used this GRM to perform a GxE analysis
applying the GCTA parameters used in the original analysis. This
script was run three times, once for each GxE. For each bootstrap
analysis, the resulting heritability estimates and P-values were
ranked and the original values compared against the 95th
percentile.
GxE Genome-wide Association Study using GWAF
Linear mixed effects model (LME) was used to test the GxE
interactions for T2D-related traits at the genome-wide level under
an additive genetic model while adjusting for age, sex, study
center, kinship and population structure. All SNP genotypes and
interactions were treated as fixed effects, while family relationship
was treated as a random effect through the kinship matrix in R
(version 2.15.0, GWAF package) [24]. Quantile-quantile (Q-Q)
plots of P-values were drawn using R.
Correction for Multiple Testing
By using an online tool called MatSpD (http://gump.qimr.edu.
au/general/daleN/matSpD/), we first calculated the number of
independent variables represented by these 15 environmental
GxE Contribution to Variation of Diabetes Traits
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factors and four diabetes-related traits to be 13 and three,
respectively. Based on these numbers, we then corrected for
multiple testing in GCTA analysis by applying Bonferroni
correction and the corrected P-value for significance is 0.001
(0.05/(1363)). For GWAS, a P-value ,1.0E-5 was considered as
statistically significant, as this is a commonly used a threshold for
discovery in GWAS (http://www.genome.gov/gwastudies/).
Results
Variance Contribution of GxE Interaction for T2D-related
Traits at the Genome-wide Level
GCTA [21] was used to estimate the contribution of genome-
wide GxE variance to T2D-related traits while adjusting for
potential confounders: age, sex, study center, and population
structure. For fasting glucose, additive genetic variance contrib-
uted 19.8% (P- nominal = 0.002) of total phenotypic variance, but
in this population, none of the variance from GxE interactions
contributed significantly to the total glucose variance (Figure 1,
Table S1). The results were similar when further adjusting for
body mass index (BMI) and no significant GxE variance
contribution was observed.
For fasting insulin, additive genetic variance accounted for
20.2% (P- nominal = 0.002) of total phenotypic variation. After
inclusion of GxE in the model, the variance explained by the
additive genetic variance varied from 10.9% to 19.5%, and
carbohydrate intake contributed significant GxE variance to the
total variance of fasting insulin (25.1%, P-nominal = 0.032)
(Table 2, Figure 1, 2, 3). The GxE variance of dietary n-3: n-
6 PUFA ratio, although not significant (P-nominal = 0.112), is
substantial (17.4%) compared to those of the other dietary or
lifestyle factors, for which GxE variances were not significant (P-
nominal .0.05) (Table S2). Inclusion of BMI into the covariates
only slightly changed the results, and the genome-wide variance
contribution by carbohydrate intake was 29.1% (P-nomi-
nal = 0.021).
For HOMA-IR, the additive genetic variance accounted for
20.9% of total variance (P-nominal = 0.001). Similar to fasting
insulin, GxE interaction of carbohydrate intake showed the most
significant contribution (P-nominal = 0.035), accounting for 24.2%
of total variance (Table 2, Figure 1, 2, 3). The GxE
contribution of carbohydrate intake was similar when further
adjusted for BMI (P-nominal = 0.02, accounting for 29.4% of total
variance). None of the GxE interactions from other dietary or
lifestyle factors contributed significantly to the total phenotypic
variance of HOMA-IR (P-nominal .0.05) (Figure 1, Table S3).
For HOMA-B, significant differences of variance contributions
were observed for most environmental factors before and after
adjustment of BMI, therefore BMI was added into the model. We
observed that 18.7% of the total variance could be explained by
the additive genetic variance (P-nominal = 0.005). The most
significant GxE variance was contributed by n-6 PUFA intake
(39.0%, P-nominal = 0.005), while the GxE variance contributed
by dietary PUFA was also significant (31.4%, P-nominal = 0.016)
Table 1. Demographic and biochemical characteristics and dietary and lifestyle data in the GOLDN population1.
Men (n=406) Women (n=414)
Mean ± SD Range (Q1–Q3) Mean ± SD Range (Q1–Q3)
Age, y 48.8615.9 38.0–62.0 49.0616.1 39.0–62.0
BMI, kg/m2 28.664.7 25.8–31.1 28.466.2 23.8–31.7
Fasting glucose (mg/dL) 105.8621.5 96.0–108.0 98.3617.0 90.0–101.0
Fasting insulin (mU/L) 14.5668.36 9.0–17.0 13.668.1 9.0–16.0
HOMA-IR 1.9361.09 1.22–2.25 1.7861.1 1.15–2.11
HOMA-B, (%) 108.8638.8 83.9–130.5 116.6636.3 91.7–135.6
Current smoker, n (%) 33 (8.1) 34 (8.2)
Current drinker, n (%) 199 (49.0) 208 (50.2)
Physical activity score 34.967.3 30.3–38.2 33.165.0 29.8–35.3
Glycemic load 145.4686.2 92.8–174.5 108.8655.7 74.5–128.3
Total energy (kcal/day) 250561501 1669–2993 17816817 1286–2099
Protein (% of total energy) 15.862.7 14.1–17.5 15.862.8 14.2–17.5
Total fat (% of total energy) 35.966.7 31.5–40.3 35.166.9 30.4–39.7
Saturated fat(% of total energy) 12.162.7 10.5–13.9 11.562.6 9.67–13.0
MUFA (% of total energy) 13.762.8 11.9–15.4 13.062.8 11.0–14.9
PUFA (% of total energy) 7.3961.99 6.05–8.41 7.9562.34 6.25–9.38
n-3 PUFA (% of total energy) 0.6860.19 0.54–0.79 0.7560.23 0.58–0.87
n-6 PUFA (% of total energy) 6.6461.83 5.45–7.61 7.1462.16 5.56–8.42
n-3: n-6 PUFA (% of total energy) 0.1060.02 0.09–0.12 0.1160.02 0.10–0.12
Carbohydrate (% of total energy) 47.568.6 41.7–53.5 50.368.1 45.0–55.4
Alcohol use (% of total energy) 2.7866.57 0.01–2.41 1.3563.35 0.01–1.14
Trans fat (% of total energy) 2.2060.58 1.82–2.50 2.1160.66 1.68–2.46
Fiber (% of total energy) 1.8260.48 1.49–2.06 2.0960.62 1.65–2.48
1Values are mean 6 SD or n (%). BMI, body mass index; SD, standard deviation; Q, quartile.
doi:10.1371/journal.pone.0077442.t001
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(Table 2, Figure 1). Another environmental factor that was a
marginally significant contributor to the GxE variance was
smoking status, which accounts for 22.0% of total HOMA-B
variance (P-nominal = 0.055) (Table 2, Table S4).
As dietary or lifestyle factors were not totally independent from
each other, we then examined whether the contribution to the
total phenotypic variance from a significant GxE interaction was
affected by other dietary or lifestyle factors. We approached this by
pairing one significant environmental factor with another factor
simultaneously in the model, while controlling for potential
confounders (Table S5). For fasting insulin, we paired carbohy-
drate intake with n-3: n-6 PUFA ratio, total fat, and smoking status
Figure 1. Estimation of GxE variance of 15 dietary and lifestyle factors for four diabetes-related traits. The GxE variance is shown as the
percentage of the total phenotypic variance of each trait. *P,0.05 indicates nominal significant contribution to total variance.
doi:10.1371/journal.pone.0077442.g001
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in the model respectively, and inclusion of either of these factors
did not remarkably change the variance contributed by the GxE of
carbohydrate intake (19.8%–23.6%). For HOMA-IR, similar to
insulin, including n-3: n-6 PUFA ratio, total fat, or smoking status
in the model did not significantly change the contribution of GxE
variance from carbohydrate intake to the total variance, and the
GxE contribution of carbohydrate varied from 19.6% to 22.6%.
For HOMA-B, inclusion of n-6 PUFA and PUFA in the model
abolished the GxE variance contributed by dietary PUFA, while
the GxE variance contributed by n-6 PUFA did not change
remarkably (45.5%). This was because of the strong correlation
between n-6 PUFA and PUFA (r = 0.89, P,0.001) in this
population and indicated that n-6 PUFA and PUFA represented
the same GxE variance for HOMA-B. Pairing total fat, MUFA,
and smoking status with n-6 PUFA in the model did not change
the GxE variance estimate of n-6 PUFA.
Influence of Major Environmental Factors on T2D-related
Traits in GxE GWAS
Using GCTA, we identified environmental factors that showed
significant GxE contributions to the variance of a given T2D-
related trait. To illustrate and confirm the results from GCTA, a
GxE GWAS was conducted. Selecting the most significant
environmental factor for each trait, we used a GWAF package
in R [24] to conduct a GxE GWAS, and a non-significant dietary
or lifestyle factor was used as a control to run the analysis. A
GWAS without GxE in the model was also conducted for each
trait as a comparison to the GxE GWAS. The significant
environmental factor for the GxE GWAS for insulin and
HOMA-IR was carbohydrate intake, while n-6 PUFA was chosen
for HOMA-B. Dietary protein intake did not contribute to the
GxE for any T2D-related trait and therefore served as a control
for all traits. We observed that, for those environmental factors
with significant GxE contribution to the phenotypic variance, the
QQ-plots were slightly off the diagonal, while for protein intake,
the QQ-plots aligned well with the diagonal compared to the
significant environmental factors (Figure S1, S2, S3).
We extracted all SNPs from each GWAS with a nominal P-
value ,1.0E-5 for the main effect and for GxE interaction for
insulin, HOMA-IR and HOMA-B (Table 3). Detailed informa-
tion for the resulting 119 SNPs is provided in Table S6. The
number of SNPs (nominal P-value for GxE ,1.0E-5) for the GxE
GWAS of carbohydrate was much larger than that of protein for
both insulin (28 SNPs vs 6) and HOMA-IR (27 SNPs vs 6). For
HOMA-B, GxE GWAS of n-6 PUFA produced a larger number
of SNPs (nominal P-value for GxE ,1.0E-5) compared with
protein control (26 SNPs vs 2).
Figure 2. Estimated amount of variance by GxE interaction of three E factors for four diabetes traits. The GxE variance is shown as the
percentage of the total phenotypic variance of each trait. *P,0.05 indicates nominal significant contribution to total variance.
doi:10.1371/journal.pone.0077442.g002
Table 2. Estimation of additive genetic variance and variance of GxE interaction for diabetes-related traits1.
Trait E factor
Nominal P-value
(gxe) Vg SE Vgxe SE h2 (g), %SE h2 (gxe), % SE h2 (g+gxe), %
Fasting insulin2 Carbohydrate 0.032 0.00048 0.00031 0.00089 0.00050 13.6 8.6 25.1 14.0 38.7
HOMA-IR2 Carbohydrate 0.035 0.0013 0.0008 0.0021 0.0012 14.5 8.6 24.2 13.9 38.7
HOMA-B3 PUFA 0.016 148.7 102.7 370.0 175.4 12.6 8.6 31.4 14.6 44.0
n-6 PUFA 0.005 105.5 104.5 459.8 180.4 8.9 8.8 39.0 14.9 48.0
Smoking status 0.055 49.0 145.1 255.7 174.9 4.2 12.5 22.0 14.9 26.2
1Vg, additive genetic variance; Vgxe, variance contributed by GxE interaction; SE, standard error; h2 (g), heritability; h2 (g + gxe), total heritability. Only the significant E
factors are listed here, while the results of other E factors are in supplemental files.
2GCTA was adjusted for age, sex, study center, kinship, and population structure.
3GCTA was adjusted for age, sex, body mass index, study center, kinship, and population structure.
doi:10.1371/journal.pone.0077442.t002
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Estimation of GxE Variance Explained by the Variants
Identified from the GxE GWAS
For each trait (insulin, HOMA-IR and HOMA-B), the SNPs
with a nominal P-value ,1.0E-5 for the main effect or GxE effect
from the corresponding GxE GWAS were extracted for the
estimate of variance contribution of these SNPs to the total
phenotypic variance using GCTA (Table 4). Both significant and
non-significant (dietary protein) environmental factors were
included in the model. For HOMA-IR, the additive genetic
variance explained by the 51 SNPs accounted for only 3.2% of the
total variance, while surprisingly, the GxE interaction of carbo-
hydrate intake represented up to 27.8% of the total variance (P-
nominal = 6.35E-25). However, the GxE interaction with protein
intake accounted for just 7.5% of the total HOMA-IR variance (P-
nominal = 6.90E-4). Similarly, GxE interaction of 49 SNPs with
carbohydrate intake explained 28.6% of total insulin variance (P-
nominal = 1.11E-23), while the GxE for protein explained 7.5%
variance of the trait (P-nominal = 5.82E-4), and the additive
genetic variance was negligible. For HOMA-B, the GxE of n-6
PUFA represented 23.3% of total variance of the trait (P-
nominal = 1.68E-22), while the variance explained by the GxE
of protein contributed only 1.4% of the total variance (P-
nominal = 0.179). Bootstrap analysis showed that our GCTA
GxE P-value falls far below the 95th percentile indicating that
these results are highly unlikely to be obtained merely by chance
(Table 4).
Discussion
In this study, we have utilized a novel approach to demonstrate
the important contribution of GxE interaction to the risk of T2D
at the genome-wide level. Using GCTA, we explored the GxE
contribution of 15 macronutrients and lifestyle factors to the total
phenotypic variance of four T2D-related traits. Our results
showed that 25.1% and 24.2% of the heritability of fasting insulin
and HOMA-IR could be explained by the GxE interaction of
carbohydrate intake with the whole genome, and that 39.0% of
the heritability of HOMA-B could be explained by the GxE
interaction of n-6 PUFA with the genome. The heritability
explained by the main effect of the genome without GxE in the
model was only 20.2%, 20.9% and 18.7% for fasting insulin,
HOMA-IR and HOMA-B, respectively. For each trait, we
Figure 3. Estimated heritability (%) of type 2 diabetes-related traits. Unfilled bars depict the heritability based on additive genetic variance.
Solid bars represent heritability, as a percentage, due to the sum of additive genetic variance and genetic variance by GxE interaction. The
corresponding environmental factor for insulin, HOMA-IR and HOMA-B was carbohydrate, carbohydrate, and n-6 PUFA, respectively.
doi:10.1371/journal.pone.0077442.g003
Table 3. Number of SNPs with nominal P-value #10E-5 based on GxE GWAS.
Trait E factor GxE1 Without GxE With GxE in the model
Main effect GxE interaction
Sum of main effect and
GxE
Insulin2 Carbohydrate Significant 8 21 28 37
Protein Non-significant 7 6 6 12
HOMA-IR2 Carbohydrate Significant 9 22 27 38
Protein Non-significant 7 7 6 13
HOMA-B3 n-6 PUFA Significant 14 15 26 37
Protein Non-significant 17 0 2 2
1The E factor has a significant or non-significant GxE variance contribution to the total phenotypic variance.
2GWAS adjusted for age, sex, study center, kinship, and population structure.
3GWAS adjusted for age, sex, body mass index, study center, kinship, and population structure.
doi:10.1371/journal.pone.0077442.t003
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selected one environmental factor with the most significant GxE
variance contribution and another one with a non-significant GxE
variance contribution as a control, and conducted GxE GWAS to
illustrate the GCTA results. For insulin and HOMA-IR,
carbohydrate intake contributed the most significant GxE and
the corresponding GxE GWAS identified 28 and 27 significant
SNPs (P,1.0E-5), respectively, and these numbers were larger
than that identified from the control factor. For HOMA-B, GCTA
identified n-6 PUFA to be the most important factor contributing
to GxE variance, and 26 significant SNPs were identified through
the GxE GWAS for n-6 PUFA, while it was only two significant
SNPs for the control dietary factor.
With the maturity of GWAS analysis, understanding the
genome-wide variance contribution of GxE interaction to the
disease phenotypes, such as T2D-related traits, is becoming a
primary interest for researchers. The first GWAS for T2D was
published in 2007 [25] and more than 30 GWAS for T2D have
been published since then [26]. Although the results produced by
these T2D GWAS were intriguing as more than 30 novel T2D loci
have been identified, a great number of genetic variants may still
be overlooked in the traditional GWAS without the influence of
GxE interaction [11]. For example, most of those GWAS-
identified SNPs were related to impaired b-cell function, while
only a few SNPs were related to insulin resistance [9,27,28],
suggesting that environmental factors may play an important role
in insulin resistance. As indicated in this study, carbohydrate
intake contributed a significant GxE variance to the variance of
insulin resistance, and GWAS including GxE into the model
explained more insulin resistance variance and greatly increased
the number of significant SNPs compared with GWAS without
GxE (Table 3).
Additional evidence supporting a potentially important role for
environmental modulation of genetic risk was found in previous
population studies. For example, although some of the GWAS-
identified T2D loci could be replicated successfully in various
populations (e.g., CDKAL1, HHEX, IGF2BP2, TCF7L2 and
SLC30A8), more genetic variants have been identified only in
some specific populations [26]. T2D risk alleles showed extreme
directional differentiation between different populations compared
with other common diseases [29]. Different T2D loci and loci
frequencies across different populations may reflect the adaptation
to the local environments and diets along with human migration
[30]. Therefore, the interplay between gene and environment
leads to a more complex pathogenesis of T2D and related traits.
These hypotheses are strongly supported by a number of recent
GxE studies [7,11,31,32]. For example, Qi et al. [31] generated a
genetic risk score (GRS) using ten GWAS-identified SNPs and
observed a significant interaction between the Western dietary
pattern and GRS in the Health Professionals Follow-Up Study.
The Western dietary pattern was only positively associated with
risk of T2D among men with a high GRS, but not with low GRS
subjects. Another large meta-analysis of 14 cohort studies [32]
revealed that dietary whole-grain intake potentially interacted with
one GCKR variant (rs780094) for fasting insulin in individuals of
European descent. Greater whole-grain intake was associated with
a smaller reduction of fasting insulin in individuals with the
insulin-raising allele of rs780094, compared to the non-risk allele.
Our study provides further evidence of a compelling nature that
GxE interactions contribute to the variance of T2D-related traits
at the genome-wide level, thereby profoundly influencing the risk
of T2D.
In the current study, different interaction patterns were
observed for different T2D-related traits. For insulin and
HOMA-IR, significant GxE variance contributions of carbohy-
drate were observed, while for HOMA-B, n-6 PUFA contributed
significantly to the GxE interaction with the genome. These
findings provided important clues for the further studies relevant
to the prevention of T2D through nutritional interventions. For
example, n-3 PUFA have been well known for their cardiopro-
tective effects [33,34] and possible beneficial effects on insulin
resistance and T2D [35,36], however meta-analyses from
prospective studies have found overall null association for n-3
PUFA and risk of T2D [37,38], and opposite trends between
Western populations (positive association) and Eastern populations
(inverse association). Results from randomized controlled trials of
n-3 PUFA on insulin resistance [39] or glycemic traits [40] were
also inconsistent. These inconsistencies may be attributed to the
GxE interaction as suggested by the present study. Variance of the
GxE interaction for n-3: n-6 PUFA ratio accounted for 15.3%
heritability of HOMA-IR, while it was 17.4% for fasting insulin.
And for fasting glucose, 11.3% heritability of glucose was
attributed to the GxE of n-3 PUFA. As the environmental factors
were population-specific, different populations may possess differ-
ent GxE patterns and different disease risk, and these different
GxE patterns may contribute to the different response of T2D risk
to n-3 PUFA intake among Western and Eastern populations.
Table 4. Estimation of heritability (%) from identified SNPs with nominal P-value ,1.0E-5 based on GxE GWAS1.










Insulin2 Carbohydrate 49 0 4.0 28.6 5.5 1.11E-23 0.028 5.68
Protein 7.2 3.1 5.82E-04
HOMA-IR2 Carbohydrate 51 3.2 4.4 27.8 5.2 6.35E-25 0.027 5.97
Protein 7.5 3.1 6.90E-04
HOMA-B3 n-6 PUFA 39 0 4.0 23.3 5.3 1.68E-22 0.025 5.33
Protein 1.4 1.7 0.179
1h2(g), heritability of additive genetic variance; h2 (gxe), heritability of GxE interaction; SE, standard error.
2P-values were adjusted for age, sex, study center, kinship, and population structure.
3P-values were adjusted for age, sex, body mass index, study center, kinship, and population structure.
495th percentile for the P-value and heritability estimate from the 10006GCTA bootstrap analysis for each trait. In each case, the GCTA GxE P-value falls below the 95th
percentile indicating that these results are highly unlikely to be obtained merely by chance.
doi:10.1371/journal.pone.0077442.t004
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Therefore, future intervention or cohort studies with regard to n-3
PUFA and T2D and related traits should always take into
consideration GxE interactions. In addition to n-3 PUFA,
carbohydrate intake showed a crucial role to interact with the
whole genome to influence insulin resistance and fasting insulin
concentration in the present study, while dietary glycemic load did
not show significant GxE on any T2D-related trait. Our previous
studies [41,42] identified PLIN1 variants that interact with the
saturated fatty acid-to-carbohydrate ratio to influence insulin
resistance. However, GxE studies that investigate relationships
between carbohydrate intake and insulin resistance remain limited
[7]. More work is clearly needed to explore the GxE of
carbohydrate intake with potential genetic variants for insulin
resistance and related traits.
Another finding of interest is the significant GxE variance
contribution of n-6 PUFA to HOMA-B. PUFAs, including both n-
3 and n-6 families, were suggested to improve insulin sensitivity
through incorporation into the cell membrane, and increased
membrane fluidity [43]. However, the mechanisms for these
effects on b-cell function are less clear. The present study indicated
that n-6 PUFA, compared to n-3 PUFA or other dietary factors,
had a greater number of interactive relationships with the genome
to affect b-cell function, and these interactions are biologically
plausible. For example, two SNPs (rs6533014 and rs6533015)
showing a significant GxE interaction with n-6 PUFA map near
the NFKB1 gene. NF-kB, an important regulator of expression of
genes involved in a variety of biological functions, is involved in
the regulation of b-cell function via control of glucose-stimulated
insulin secretion [44]. Another example was that eight of those 26
SNPs showing a significant GxE interaction with n-6 PUFA are
located in the FAT3-MTNR1B region (Table S6). GWAS have
identified several SNPs in this region to be associated with T2D
and fasting glucose [3,26]. Therefore, n-6 PUFA may interact with
genetic variants in this region to regulate glucose and b-cell
function, thereby affecting T2D risk. However, the precise
mechanisms by which n-6 PUFA influences b-cell function via
the NF-kB pathway or FAT3-MTNR1B region, and the function of
the identified SNPs warrants further investigation. Nevertheless,
these findings provided insight into the extent of the interplay of n-
6 PUFA with the genome in regard to b-cell function.
Possible overestimation of genetic and GxE variance may be a
limitation of this study, as GOLDN is a family-based population,
and causal genetic variants might be captured by pedigree instead
of SNPs [6,45]. Similar dietary and lifestyle factors within a family
would also bias the variance estimation. Second, the moderate
sample size of the present study only allowed us to estimate GxE
variance for each environmental factor separately. In addition, the
sum of the heritability explained by the environmental factors was
more than 100%; this rose from the high correlations between
several of the environmental factors. Third, none of the GCTA
results passed the Bonferroni correction (P,0.001). Nevertheless,
our GxE GWAS confirmed the GCTA results, and a great
difference was observed between the significant environmental
factor and the control factor for each trait. Fourth, GCTA based
on those GxE GWAS-identified SNPs further confirmed the
primary GCTA results. Overall, we have shown that adding a
GxE interaction into the GWAS model explained a greater degree
of heritability for three T2D-related traits than examining genetic
effects alone. These results indicate the importance of examining
GxE interactions to explain the variance of T2D-related traits. In
addition, our results were observed in a European population
living in the U.S.A, and may not be applicable to other
populations with different genotypes, ancestry, haplotypes, or
different cultures and their different lifestyle choices.
In conclusion, we have presented a new approach to
demonstrate the important contribution of GxE interaction at
the genome-wide level to the heritability of T2D-related traits. In
contrast to traditional GWAS, GxE GWAS has the potential to
unveil novel genetic variants associated with disease risk, and,
importantly, those whose risk is potentially modifiable by lifestyle
intervention. The methods presented herein will facilitate a better
prediction of T2D and can also be applied to the prediction of
other diseases, especially metabolic diseases and cancer for which
we have noted many GxE interactions are already known.
Supporting Information
Figure S1 QQ-plot: Fasting insulin.
(DOCX)
Figure S2 QQ-plot: HOMA-IR.
(DOCX)
Figure S3 QQ-plot: HOMA-B.
(DOCX)
Table S1 Estimation of additive genetic variance and variance
of GxE interaction for fasting glucose.
(DOCX)
Table S2 Estimation of additive genetic variance and variance
of GxE interaction for fasting insulin.
(DOCX)
Table S3 Estimation of additive genetic variance and variance
of GxE interaction for HOMA-IR.
(DOCX)
Table S4 Estimation of additive genetic variance and variance
of GxE interaction for HOMA-B.
(DOCX)
Table S5 Estimation of GxE variance for paired environmental
factors on T2D traits.
(DOCX)




We thank the staff of the GOLDN study for the assistance in data
collection and management. Mention of trade names or commercial
products in this publication is solely for the purpose of providing specific
information and does not imply recommendation or endorsement by the
U.S. Department of Agriculture. The USDA is an equal opportunity
provider and employer.
Author Contributions
Conceived and designed the experiments: CQL JMO DKA IBB. Analyzed
the data: JSZ CQL. Wrote the paper: JSZ. Contributed to interpretation of
the results: JSZ DKA YCL JS LDP CES KR DL IBB JMO CQL.
Reviewed and edited the manuscript and approved the final version of the
article: JSZ DKA YCL JS LDP CES KR DL IBB JMO CQL.
GxE Contribution to Variation of Diabetes Traits
PLOS ONE | www.plosone.org 8 October 2013 | Volume 8 | Issue 10 | e77442
References
1. Pala V, Krogh V, Muti P, Chajes V, Riboli E, et al. (2001) Erythrocyte
membrane fatty acids and subsequent breast cancer: a prospective Italian study.
J Natl Cancer Inst 93: 1088–1095.
2. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4–14.
3. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve
type 2 diabetes susceptibility loci identified through large-scale association
analysis. Nat Genet 42: 579–589.
4. Billings LK, Florez JC (2010) The genetics of type 2 diabetes: what have we
learned from GWAS? Ann N Y Acad Sci 1212: 59–77.
5. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009)
Finding the missing heritability of complex diseases. Nature 461: 747–753.
6. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010)
Common SNPs explain a large proportion of the heritability for human height.
Nat Genet 42: 565–569.
7. Lee YC, Lai CQ, Ordovas JM, Parnell LD (2011) A Database of Gene-
Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular
Disease and Type 2 Diabetes. J Data Mining Genomics Proteomics 2.
8. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, et al. (2001) Diet, lifestyle,
and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790–797.
9. Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes.
Diabetes Care 34: 1249–1257.
10. Visscher PM, Hill WG, Wray NR (2008) Heritability in the genomics era–
concepts and misconceptions. Nat Rev Genet 9: 255–266.
11. Cornelis MC, Hu FB (2012) Gene-Environment Interactions in the Develop-
ment of Type 2 Diabetes: Recent Progress and Continuing Challenges. Annu
Rev Nutr 32: 245–259.
12. Corella D, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, et al. (2007)
The-256T.C polymorphism in the apolipoprotein A-II gene promoter is
associated with body mass index and food intake in the genetics of lipid lowering
drugs and diet network study. Clin Chem 53: 1144–1152.
13. Lai CQ, Arnett DK, Corella D, Straka RJ, Tsai MY, et al. (2007) Fenofibrate
effect on triglyceride and postprandial response of apolipoprotein A5 variants:
the GOLDN study. Arterioscler Thromb Vasc Biol 27: 1417–1425.
14. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, et al. (2008)
Integrated genotype calling and association analysis of SNPs, common copy
number polymorphisms and rare CNVs. Nat Genet 40: 1253–1260.
15. Aslibekyan S, Kabagambe EK, Irvin MR, Straka RJ, Borecki IB, et al. (2012) A
genome-wide association study of inflammatory biomarker changes in response
to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet
Network. Pharmacogenet Genomics 22: 191–197.
16. Kim EH, Willett WC, Colditz GA, Hankinson SE, Stampfer MJ, et al. (2006)
Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up.
Am J Epidemiol 164: 990–997.
17. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, et al. (2001)
Comparative validation of the Block, Willett, and National Cancer Institute food
frequency questionnaires : the Eating at America’s Table Study. Am J Epidemiol
154: 1089–1099.
18. Thompson FE, Subar AF, Brown CC, Smith AF, Sharbaugh CO, et al. (2002)
Cognitive research enhances accuracy of food frequency questionnaire reports:
results of an experimental validation study. J Am Diet Assoc 102: 212–225.
19. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model
assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:
2191–2192.
20. Box GEP, Cox DR (1964) An Analysis of Transformations. J R Stat Soc B 26:
211–252.
21. Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: a tool for genome-
wide complex trait analysis. Am J Hum Genet 88: 76–82.
22. Patterson N, Price AL, Reich D (2006) Population structure and eigenanalysis.
PLoS Genet 2: e190.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006)
Principal components analysis corrects for stratification in genome-wide
association studies. Nat Genet 38: 904–909.
24. Chen MH, Yang Q (2010) GWAF: an R package for genome-wide association
analyses with family data. Bioinformatics 26: 580–581.
25. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide
association study identifies novel risk loci for type 2 diabetes. Nature 445: 881–
885.
26. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009)
Potential etiologic and functional implications of genome-wide association loci
for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
27. Ahlqvist E, Ahluwalia TS, Groop L (2011) Genetics of type 2 diabetes. Clin
Chem 57: 241–254.
28. Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key
cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:
1100–1110.
29. Chen R, Corona E, Sikora M, Dudley JT, Morgan AA, et al. (2012) Type 2
Diabetes Risk Alleles Demonstrate Extreme Directional Differentiation among
Human Populations, Compared to Other Diseases. Plos Genetics 8: 100–115.
30. Lai CQ (2012) Adaptive genetic variation and population differences. Prog Mol
Biol Transl Sci 108: 461–489.
31. Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB (2009) Genetic
predisposition, Western dietary pattern, and the risk of type 2 diabetes in men.
Am J Clin Nutr 89: 1453–1458.
32. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, et al. (2010)
Interactions of dietary whole-grain intake with fasting glucose- and insulin-
related genetic loci in individuals of European descent: a meta-analysis of 14
cohort studies. Diabetes Care 33: 2684–2691.
33. He K (2009) Fish, Long-Chain Omega-3 Polyunsaturated Fatty Acids and
Prevention of Cardiovascular Disease-Eat Fish or Take Fish Oil Supplement?
Prog Cardiovasc Dis 52: 95–114.
34. Zheng J, Huang T, Yu Y, Hu X, Yang B, et al. (2011) Fish consumption and
CHD mortality: an updated meta-analysis of seventeen cohort studies. Public
Health Nutr 15: 725–737.
35. Fedor D, Kelley DS (2009) Prevention of insulin resistance by n-3
polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12: 138–146.
36. Villegas R, Xiang YB, Elasy T, Li HL, Yang G, et al. (2011) Fish, shellfish, and
long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in
middle-aged Chinese men and women. Am J Clin Nutr 94: 543–551.
37. Xun P, He K (2012) Fish Consumption and Incidence of Diabetes: Meta-
analysis of data from 438,000 individuals in 12 independent prospective cohorts
with an average 11-year follow-up. Diabetes Care 35: 930–938.
38. Zheng JS, Huang T, Yang J, Fu YQ, Li D (2012) Marine N-3 polyunsaturated
Fatty acids are inversely associated with risk of type 2 diabetes in asians: a
systematic review and meta-analysis. PLoS One 7: e44525.
39. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L (2011) Omega-3 polyunsaturated
fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials.
Clin Nutr.
40. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, et al. (2008) Omega-3
polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane
Database Syst Rev: CD003205.
41. Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, et al. (2006) Perilipin
gene variation determines higher susceptibility to insulin resistance in Asian
women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes
Care 29: 1313–1319.
42. Smith CE, Arnett DK, Corella D, Tsai MY, Lai CQ, et al. (2012) Perilipin
polymorphism interacts with saturated fat and carbohydrates to modulate insulin
resistance. Nutr Metab Cardiovasc Dis 22: 449–455.
43. Manco M, Calvani M, Mingrone G (2004) Effects of dietary fatty acids on
insulin sensitivity and secretion. Diabetes Obes Metab 6: 402–413.
44. Norlin S, Ahlgren U, Edlund H (2005) Nuclear factor-kappa B activity in beta-
cells is required for glucose-stimulated insulin secretion. Diabetes 54: 125–132.
45. Visscher PM, Yang J, Goddard ME (2010) A commentary on ‘common SNPs
explain a large proportion of the heritability for human height’ by Yang et al.
(2010). Twin Res Hum Genet 13: 517–524.
GxE Contribution to Variation of Diabetes Traits
PLOS ONE | www.plosone.org 9 October 2013 | Volume 8 | Issue 10 | e77442
